We are live on ! Find out more
OWD

Osborn Williams & Donohoe Portfolio holdings

AUM $762M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
-2.74%
3 Year Est. Return
+23.69%
5 Year Est. Return
+43.75%
10 Year Est. Return
AUM
$1B
AUM Growth
+$7.18M
Cap. Flow
-$69.8M
Cap. Flow %
-6.98%
Top 10 Hldgs %
22.66%
Holding
320
New
18
Increased
64
Reduced
177
Closed
18

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$7.51M
2
TGT icon
Target
TGT
+$3.7M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.17M
4
BALL icon
Ball Corp
BALL
+$835K
5
RWT
Redwood Trust
RWT
+$832K

Sector Composition

Rank Sector Weight
1 Financials 16.37%
2 Technology 16.27%
3 Healthcare 16.13%
4 Consumer Staples 10.21%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
201
Cigna
CI
$73.7B
$654K 0.07%
3,199
-1,354
-30% -$248K
JCI icon
202
Johnson Controls International
JCI
$88.8B
$642K 0.06%
15,782
-4,704
-23% -$198K
SHW icon
203
Sherwin-Williams
SHW
$82.7B
$636K 0.06%
3,270
-30
-0.9% -$5.72K
NI icon
204
NiSource
NI
$21.3B
$615K 0.06%
22,083
-6,270
-22% -$172K
ETN icon
205
Eaton
ETN
$161B
$604K 0.06%
+6,375
New +$566K
GLW icon
206
Corning
GLW
$119B
$603K 0.06%
20,725
+1,170
+6% +$34K
TTE icon
207
TotalEnergies
TTE
$195B
$602K 0.06%
+10,890
New +$576K
UN
208
DELISTED
Unilever NV New York Registry Shares
UN
$597K 0.06%
10,390
MEDP icon
209
Medpace
MEDP
$16.1B
$588K 0.06%
7,000
-6,976
-50% -$540K
ZTS icon
210
Zoetis
ZTS
$32.4B
$588K 0.06%
4,445
+2,475
+126% +$308K
ROP icon
211
Roper Technologies
ROP
$38.8B
$584K 0.06%
1,650
+100
+6% +$34.5K
EA icon
212
Electronic Arts
EA
$53B
$578K 0.06%
5,375
+325
+6% +$32.3K
NSC icon
213
Norfolk Southern
NSC
$75.4B
$576K 0.06%
2,968
CTAS icon
214
Cintas
CTAS
$81.9B
$572K 0.06%
8,496
+20
+0.2% +$1.31K
VLO icon
215
Valero Energy
VLO
$90.1B
$562K 0.06%
6,002
-340
-5% -$32.1K
MLM icon
216
Martin Marietta Materials
MLM
$31.5B
$558K 0.06%
1,995
+320
+19% +$85.3K
PLD icon
217
Prologis
PLD
$135B
$558K 0.06%
6,255
+850
+16% +$75.3K
IAU icon
218
iShares Gold Trust
IAU
$62.9B
$554K 0.06%
19,118
+597
+3% +$16.9K
ET icon
219
Energy Transfer Partners
ET
$70.1B
$551K 0.06%
42,982
-4,800
-10% -$59.1K
BKNG icon
220
Booking.com
BKNG
$149B
$544K 0.05%
+6,625
New +$520K
IVE icon
221
iShares S&P 500 Value ETF
IVE
$49B
$538K 0.05%
4,136
-200
-5% -$24.9K
CAH icon
222
Cardinal Health
CAH
$53.9B
$532K 0.05%
10,520
-3,175
-23% -$164K
KIN
223
DELISTED
Kindred Biosciences, Inc.
KIN
$532K 0.05%
62,700
HACK icon
224
Amplify Cybersecurity ETF
HACK
$2.68B
$522K 0.05%
12,575
-3,968
-24% -$159K
ERTH icon
225
Invesco MSCI Sustainable Future ETF
ERTH
$133M
$499K 0.05%
10,000

Similar funds

Osborn Williams & Donohoe's Q4 2019 Portfolio in Review

As of Q4 2019, Osborn Williams & Donohoe held 320 positions worth $1B, up 0.72% from $993M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Osborn Williams & Donohoe withdrew a net $69.8M in Q4 2019, closing 18 positions and reducing 177 holdings. Its most notable exit was Celgene Corp, an estimated $3.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Osborn Williams & Donohoe opened a new position in Accenture worth $8.11M.

  • Osborn Williams & Donohoe's largest Q4 2019 buy was Accenture: 38,523 shares worth $8.11M.
  • Osborn Williams & Donohoe added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.17M increase.
  • Osborn Williams & Donohoe's biggest Q4 2019 reduction was Cincinnati Financial, cutting an estimated $8.78M.
  • Osborn Williams & Donohoe fully exited Celgene Corp in Q4 2019, selling an estimated $3.9M.
  • Osborn Williams & Donohoe's ten largest holdings make up 23% of its $1B portfolio in Q4 2019.
  • Osborn Williams & Donohoe opened 18 new positions and closed 18 in Q4 2019.
  • Osborn Williams & Donohoe's portfolio value rose 0.72% quarter-over-quarter to $1B.

Based on Osborn Williams & Donohoe's 13F filing for Q4 2019, filed 2 Mar 2020.